Nature Methods 'Under Consideration': What Each Status Means and Realistic Timelines

Nature Methods isn't interested in every new assay or pipeline. The editors are looking for something specific, and if you don't hit it, you'll get a polite rejection within two weeks regardless of how good the science is.

Here's what the desk screen really comes down to:

• Broad applicability. The method must be useful to researchers outside your subfield. A new imaging protocol that only works on retinal organoids won't make it, even if the protocol is technically brilliant. The editor is asking: "How many of our readers could actually use this?"
• Genuine novelty. Not a 15% improvement over the current standard. The method needs to open a new capability or solve a problem that existing tools can't. Incremental speed gains or minor accuracy bumps get redirected.

• Rigorous benchmarking. This is where many good papers fail at Nature Methods. If you haven't compared your method head-to-head against existing alternatives on standardized or realistic datasets, the editor won't send it out. They've seen too many papers where the "new" method only looks good because the comparison was rigged or absent.

• Usability by other labs. Can someone without your specific expertise reproduce this? Is the code available? Are the reagents commercially obtainable? A method that requires three custom-built instruments and a postdoc who trained in your lab isn't going to fly.

The editor who's reading your paper has probably seen 30 submissions that week. They're not looking for reasons to send it to review. They're looking for reasons to reject it quickly so they can focus on the papers that clearly belong. Your paper needs to answer "why this journal, why now" in the first two pages.

Nature Methods uses professional, full-time editors. They're not faculty members squeezing in editorial work between grants and teaching. This means they're fast, they're experienced, and they've developed a strong intuition for what survives peer review at this journal.

During the desk screen, the editor reads your abstract and introduction, skims the figures, and checks whether the benchmarking section exists and looks reasonable. They'll also glance at supplementary materials, because a methods paper with 40 supplementary figures and 3 main figures usually signals that the central story isn't clear enough.

If your paper is still Under Consideration after day 14, you're almost certainly past the desk. Desk rejections at Nature Methods are usually fast. Most arrive within 7-10 days. If you haven't heard anything by week 3, reviewers have likely been invited.

One pattern that catches people off guard: the editor may send your paper to one trusted colleague for an informal opinion before deciding to send it for full review. This isn't peer review. It's a second opinion on whether the paper is worth the effort of formal evaluation. You won't know this is happening, and it can add 3-5 days to the desk phase.

If you've cleared the desk, the editor needs to find 2-3 reviewers. For Nature Methods, this is often harder than at other journals. The editor needs people who understand both the methodological innovation and the biological application. A pure statistician might not grasp the wet-lab constraints. A biologist might not be able to evaluate the computational claims.

Reviewer invitation acceptance rates have dropped across all journals in recent years. It's not uncommon for an editor to invite 6-8 people before getting 3 confirmed reviewers. Each declined invitation adds a few days.

You can't do anything about this, and the journal won't tell you it's happening. But if you're sitting at Under Consideration for 3-4 weeks and starting to worry, this is probably what's going on. Don't panic.

Nature Methods reviewers are typically given 2-3 weeks to submit their reports. Some are punctual. Others aren't. The editor sends reminders but can't force compliance.

This journal's reviewers are looking at your paper through a specific lens that's different from a typical biology journal:

• Does the method actually work as claimed? Not on cherry-picked examples, but across realistic use cases. Reviewers will scrutinize edge cases and failure modes.

• Is the benchmarking fair? If you've only compared against a straw man, or if you've tuned your method on the test set and compared against methods that weren't tuned the same way, reviewers will catch it. This is the single most common source of negative reviews.

• Can someone reproduce this? Code availability, data availability, protocol detail. Nature Methods is strict about reproducibility. If your code is "available upon request" rather than in a public repository, that's a problem.

• Are the performance claims supported by the statistics? Overclaiming is common in methods papers. If your method is 5% better on one metric but 10% worse on another, and your abstract only mentions the first, reviewers will flag it.

• Is the biological validation meaningful? A computational method tested only on simulated data won't cut it. A wet-lab method tested only in one cell line is risky. Reviewers want to see that you've pushed the method into realistic, messy, real-world scenarios.

Based on typical Nature Methods revision letters, expect reviewers to ask for:

• Additional benchmarking against a method you didn't include (there's always one more competitor)
• Testing on a different biological system or dataset
• Better documentation of failure modes and limitations
• Runtime or resource comparisons (especially for computational methods)
• Demonstration by someone who didn't develop the method
• More rigorous statistical analysis of performance differences

These aren't minor requests. A typical Nature Methods revision takes 2-4 months because it often means running new experiments or analyses.

Once reports are in, the editor weighs them and decides. Here's what each outcome means in practice:

Minor revision, Rare on first submission, but it happens. Usually means the reviewers liked the method and want small clarifications. You'll have 1-2 months to respond, but most people finish in 2-3 weeks. Acceptance after minor revision is close to guaranteed.

Major revision, The most common positive outcome at Nature Methods. You'll need to address every reviewer comment, probably run additional benchmarks, and possibly test your method in a new context. The revision letter matters enormously. Don't treat it as a formality. Each response should be specific and include new data where requested.

Reject with encouragement to resubmit, This is a gray area. The editor thinks the method has potential but isn't convinced yet. If you get this, read the reviewer comments carefully. If the requested work is feasible within 3-6 months, it's usually worth doing.

Reject after review, The reviewers found fundamental issues. Either the method doesn't perform as claimed, the novelty isn't there, or the benchmarking revealed problems. The detailed reviewer comments are still valuable for improving the paper before submitting elsewhere.

Keep any follow-up email short. One or two sentences: "I'm writing to inquire about the status of manuscript NMETH-XX-XXXXX, submitted on [date]. I'd appreciate any update on the expected timeline." That's it. Don't include a list of reasons your paper is important.

If you're wondering whether Nature Methods was the right choice, or where to go if it doesn't work out, here's how these three compare in editorial philosophy:

Nature Methods wants the method itself to be the story. The biological application matters, but it's there to validate the method, not the other way around. If your paper is really a biology paper with a new tool attached, Nature Methods isn't the right fit. Impact factor is around 28.5 (JCR 2024), and the journal expects methods with broad cross-disciplinary appeal.

Nature Protocols doesn't want novelty in the same way. It wants a proven, validated protocol that other labs need to follow step by step. If your method has already been published and you're writing a detailed how-to guide, that's Nature Protocols territory. Think of it as the cookbook version. The method should already be established and widely requested.

Bioinformatics (IF ~5.8) is a strong home for computational tools that are technically sound but may not have the broad biological impact Nature Methods demands. The review process is faster (often 4-6 weeks), the desk rejection rate is much lower, and the reviewers focus more on algorithmic correctness and software quality than on broad biological applicability.

If your paper is a new sequencing analysis tool, you might also consider Genome Biology (IF ~10.1), which sits between Bioinformatics and Nature Methods in terms of scope and selectivity. For structural biology methods, Nature Structural & Molecular Biology is sometimes a better fit than Nature Methods.

These are patterns that consistently lead to rejection. Check your manuscript against them before submission:

The "it works on our data" paper. You've developed a method and tested it only on your own datasets. Reviewers will want to see performance on independent, publicly available benchmarks. If those don't exist for your problem, you need to explain why and provide other evidence of generalizability.

The missing comparison. You've benchmarked against three existing methods but left out the obvious fourth one that happens to be the current community standard. The editor and reviewers will notice. If you left it out because your method doesn't beat it, that's a bigger problem you need to address honestly.

Overclaimed generality. Your abstract says the method is "broadly applicable" but you've only tested it on one organism, one data type, or one experimental condition. At Nature Methods, "broadly applicable" means you've demonstrated it.

No code or data availability. For computational methods, this is an automatic flag. Even for wet-lab methods, Nature Methods expects detailed protocols, reagent lists, and ideally video protocols or step-by-step guides in the supplementary materials.

The wrapper paper. You've built a user-friendly interface around an existing method. Unless the interface itself enables fundamentally new analyses or dramatically changes accessibility, this won't clear the desk. Convenience alone isn't enough.

In our pre-submission review work with manuscripts targeting Nature Methods, three failure patterns generate the most consistent desk rejections and major revision requests. We find these across manuscripts we've reviewed through our Nature Methods submission readiness check.

The method validated only on the authors' own datasets. Nature Methods expects demonstration of generalizability on independent benchmarks. We observe that papers testing a new computational or experimental method exclusively on data collected by the developing group generate reviewer requests for independent benchmark testing in the majority of cases. Papers that include testing on at least one publicly available independent dataset or established community benchmark clear this standard; papers that do not receive this as the first major revision request in approximately 60% of cases we review. For wet-lab methods, demonstrating performance in materials not prepared by the developing lab serves the same function.

The missing comparison to the method reviewers are waiting for. Reviewers at Nature Methods specifically ask whether the obvious comparison was excluded because the new tool does not outperform it. We find that papers benchmarking against established methods but excluding the most widely used or most recently published alternative generate reviewer requests for the missing comparison in nearly every case. SciRev community data for Nature Methods consistently identifies "missing benchmark against the current standard" as a top revision request. A systematic search of the past 18 months of Nature Methods and Bioinformatics before finalizing comparison tables prevents this predictable request.

The generalizability claim unsupported by cross-context demonstrations. Nature Methods evaluates whether claims of broad applicability are supported by demonstration across the stated contexts. We observe that papers describing a method as "broadly applicable across sequencing modalities" while testing only RNA-seq data generate reviewer comments questioning the generalizability claim in over half of cases. The fix is either to narrow the claim to match the experiments or to add one additional demonstration in a different data type, organism, or experimental context that supports the broader framing.